MDCX - Medicus Pharma Ltd. Common Stock Stock Analysis | Stock Taper

SCREENER COMPARE ANY 2 STOCKS

MDCX

MEDICUS PHARMA LTD. COMMON STOCK

NASDAQ

$0.26

▼ DOWN 3.77% (-0.01)

KEY STATISTICS

Market Cap$5.68 M

52w High$3.05

52w Low$0.24

Dividend Yield—

Frequency—

P/E-0.13

Volume578.52K

Shares Out.22.04M

COMPANY

LEADERSHIP

Raza Bokhari

CHIEF EXECUTIVE

Raza Bokhari

ABOUT

SECTOR

Healthcare

WENT PUBLIC

November 15, 2024

METHOD OF GOING PUBLIC

N/A

FULL TIME EMPLOYEES

16

PRICE TARGET

Target High$1.00

Target Low$1.00

Target Median$1.00

Target Consensus$1.00

UPCOMING EARNINGS

DateNov 13, 2026

DayFriday

Rev. Est.—

NOV

13

FRI

PRICE

$0.26 ▼ DOWN 3.77% (−$0.01)

About Medicus Pharma Ltd. Common Stock

https://medicuspharma.com ↗

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.

INDUSTRY

Biotechnology

A PRODUCT MEDICUS PHARMA LTD. COMMON STOCK IS KNOWN FOR

Teverelix

Teverelix

Teverelix is a next-generation long-acting GnRH antagonist for advanced prostate cancer with high cardiovascular risk, recently FDA-cleared in February 2026 for a Phase 2b dose-optimization study, developed by Medicus Pharma.

COMPETITORS

COMPETITOR

ETFS HOLDING THIS STOCK

ETFS HOLDING

1

LISTED HERE

1

RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED

10.29%

HOLDERS

20

TOP 12 OF 20 · RANKED BY POSITION SIZE

Interchange Capital Partners, LLC

1.7M sh · $6.18M

Private Advisor Group, LLC

240.1K sh · $110.19K

Virtu Financial LLC

74.0K sh · $34K

Bryn Mawr Trust Co

51.2K sh · $23.52K

May Hill Capital, LLC

50.6K sh · $23.24K

Commonwealth Equity Services, LLC

48.1K sh · $22.1K

40.4K sh · $18.56K

Blackrock, Inc.

37.3K sh · $17.12K

Citadel Advisors LLC

17.8K sh · $8.18K

Two Sigma Securities, LLC

15.6K sh · $7.17K

Lpl Financial LLC

15.6K sh · $7.17K

Marathon Capital Management

15.5K sh · $7.12K

RATINGS SNAPSHOT

Overall rating: C+

Discounted Cash Flow4

Return On Equity5

Return On Assets1

Debt To Equity1

Price To Earnings1

Price To Book1

Overall Score2

INSIDER TRADES

★

OFFICER: PRESIDENT AND CFO

Bonner Carolyn F.

Purchase · 250.0K shares

2026-06-03

★

DIRECTOR

Ciaruffoli Robert J.

Purchase · 50.0K shares

2026-06-03

★

OFFICER: CHIEF SCIENTIFIC OFFICER

Brennan Edward J.

Purchase · 25.0K shares

2026-06-03

★

DIRECTOR

Kaiser Larry

Purchase · 50.0K shares

2026-06-03

MOST RECENT ANALYST GRADES

GRADE SUMMARY

BUY 1

1 GRADES IN THE LAST 12 MONTHS

D. Boral Capital BUY

SECTORS PEERS

PEER	PRICE
IPSC	$2.02	COMPARE
TELO	$1.14	COMPARE
CUE	$27.88	COMPARE
INMB	$2.33	COMPARE
ALGS	$6.91	COMPARE
KPTI	$1.87	COMPARE
BRNS	$0.75	COMPARE
SKYE	$1.77	COMPARE